Fresenius Kabi Deutschland Gmbh

Ulrich Suchner

Barbara Kessler

Ewald Schlotzer

Barbara Krampitz

Angelika Riedel

The invention relates to a composition comprising a combination of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). The composition can be used for enhancing the activity of chemotherapy or radiotherapy and/or in the prevention or reduction of side effects caused by the chemotherapy or radiotherapy in a patient ill with cancer, the composition being intended for administration to the patient prior to the commencement of a cycle of chemotherapy or radiotherapy.

Composition comprising a combination of DHA and EPA for administration prior to commencement of chemotherapy

A supplement to be administered enterally to maintain or restore the intestinal intestinal barrier of the critically or chronically ill and people with malnutrition is described. This contains as solution, in each case based on a daily dose,

Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition

Growing community of inventors

Erding, Germany

Ulrich Suchner